Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
by
Walker, John A.
, van Boxtel, Ruben
, Witzigmann, Dominik
, Oka, Rurika
, Egli, Sabina
, Pardi, Norbert
, Kontarakis, Zacharias
, Lin, Paulo J. C.
, Kissling, Lucas
, Frey, Nina
, Dennis, Melissa K.
, Thöny, Beat
, Villiger, Lukas
, Hruzova, Martina
, Bakker, Noëlle
, Semple, Sean C.
, Kreutzer, Susanne
, Häberle, Johannes
, Lenggenhager, Daniela
, Jinek, Martin
, Pacesa, Martin
, Stoffel, Markus
, Holden, Kevin
, Weissman, Drew
, Tam, Ying K.
, Rothgangl, Tanja
, Moor, Andreas
, Borrelli, Costanza
, Schwank, Gerald
, Kadina, Anastasia P.
, Victorov, Denis V.
, Qi, Weihong
in
631/1647/1511
/ 631/61/201/2110
/ Adenine
/ Agriculture
/ Animals
/ Bioinformatics
/ Biomedical and Life Sciences
/ Biomedical Engineering/Biotechnology
/ Biomedicine
/ Biotechnology
/ Cholesterol
/ Cholesterol, LDL - blood
/ Cholesterol, LDL - genetics
/ Deoxyribonucleic acid
/ DNA
/ Dosage
/ Editing
/ Gene Editing - methods
/ Genetic aspects
/ Identification and classification
/ Immune response
/ Immune response (humoral)
/ Life Sciences
/ Lipids
/ Liver - metabolism
/ Liver diseases
/ Low density lipoprotein
/ Low density lipoproteins
/ Macaca
/ Macaques
/ Male
/ Measurement
/ Mice
/ Mice, Inbred C57BL
/ mRNA
/ Mutation
/ Nanoparticles
/ Physiological aspects
/ Proprotein Convertase 9 - genetics
/ Reduction
/ RNA, Guide, CRISPR-Cas Systems
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
by
Walker, John A.
, van Boxtel, Ruben
, Witzigmann, Dominik
, Oka, Rurika
, Egli, Sabina
, Pardi, Norbert
, Kontarakis, Zacharias
, Lin, Paulo J. C.
, Kissling, Lucas
, Frey, Nina
, Dennis, Melissa K.
, Thöny, Beat
, Villiger, Lukas
, Hruzova, Martina
, Bakker, Noëlle
, Semple, Sean C.
, Kreutzer, Susanne
, Häberle, Johannes
, Lenggenhager, Daniela
, Jinek, Martin
, Pacesa, Martin
, Stoffel, Markus
, Holden, Kevin
, Weissman, Drew
, Tam, Ying K.
, Rothgangl, Tanja
, Moor, Andreas
, Borrelli, Costanza
, Schwank, Gerald
, Kadina, Anastasia P.
, Victorov, Denis V.
, Qi, Weihong
in
631/1647/1511
/ 631/61/201/2110
/ Adenine
/ Agriculture
/ Animals
/ Bioinformatics
/ Biomedical and Life Sciences
/ Biomedical Engineering/Biotechnology
/ Biomedicine
/ Biotechnology
/ Cholesterol
/ Cholesterol, LDL - blood
/ Cholesterol, LDL - genetics
/ Deoxyribonucleic acid
/ DNA
/ Dosage
/ Editing
/ Gene Editing - methods
/ Genetic aspects
/ Identification and classification
/ Immune response
/ Immune response (humoral)
/ Life Sciences
/ Lipids
/ Liver - metabolism
/ Liver diseases
/ Low density lipoprotein
/ Low density lipoproteins
/ Macaca
/ Macaques
/ Male
/ Measurement
/ Mice
/ Mice, Inbred C57BL
/ mRNA
/ Mutation
/ Nanoparticles
/ Physiological aspects
/ Proprotein Convertase 9 - genetics
/ Reduction
/ RNA, Guide, CRISPR-Cas Systems
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
by
Walker, John A.
, van Boxtel, Ruben
, Witzigmann, Dominik
, Oka, Rurika
, Egli, Sabina
, Pardi, Norbert
, Kontarakis, Zacharias
, Lin, Paulo J. C.
, Kissling, Lucas
, Frey, Nina
, Dennis, Melissa K.
, Thöny, Beat
, Villiger, Lukas
, Hruzova, Martina
, Bakker, Noëlle
, Semple, Sean C.
, Kreutzer, Susanne
, Häberle, Johannes
, Lenggenhager, Daniela
, Jinek, Martin
, Pacesa, Martin
, Stoffel, Markus
, Holden, Kevin
, Weissman, Drew
, Tam, Ying K.
, Rothgangl, Tanja
, Moor, Andreas
, Borrelli, Costanza
, Schwank, Gerald
, Kadina, Anastasia P.
, Victorov, Denis V.
, Qi, Weihong
in
631/1647/1511
/ 631/61/201/2110
/ Adenine
/ Agriculture
/ Animals
/ Bioinformatics
/ Biomedical and Life Sciences
/ Biomedical Engineering/Biotechnology
/ Biomedicine
/ Biotechnology
/ Cholesterol
/ Cholesterol, LDL - blood
/ Cholesterol, LDL - genetics
/ Deoxyribonucleic acid
/ DNA
/ Dosage
/ Editing
/ Gene Editing - methods
/ Genetic aspects
/ Identification and classification
/ Immune response
/ Immune response (humoral)
/ Life Sciences
/ Lipids
/ Liver - metabolism
/ Liver diseases
/ Low density lipoprotein
/ Low density lipoproteins
/ Macaca
/ Macaques
/ Male
/ Measurement
/ Mice
/ Mice, Inbred C57BL
/ mRNA
/ Mutation
/ Nanoparticles
/ Physiological aspects
/ Proprotein Convertase 9 - genetics
/ Reduction
/ RNA, Guide, CRISPR-Cas Systems
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
Journal Article
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
2021
Request Book From Autostore
and Choose the Collection Method
Overview
Most known pathogenic point mutations in humans are C•G to T•A substitutions, which can be directly repaired by adenine base editors (ABEs). In this study, we investigated the efficacy and safety of ABEs in the livers of mice and cynomolgus macaques for the reduction of blood low-density lipoprotein (LDL) levels. Lipid nanoparticle–based delivery of mRNA encoding an ABE and a single-guide RNA targeting
PCSK9
, a negative regulator of LDL, induced up to 67% editing (on average, 61%) in mice and up to 34% editing (on average, 26%) in macaques. Plasma PCSK9 and LDL levels were stably reduced by 95% and 58% in mice and by 32% and 14% in macaques, respectively. ABE mRNA was cleared rapidly, and no off-target mutations in genomic DNA were found. Re-dosing in macaques did not increase editing, possibly owing to the detected humoral immune response to ABE upon treatment. These findings support further investigation of ABEs to treat patients with monogenic liver diseases.
Base editors are effective and safe for cholesterol reduction in non-human primates.
Publisher
Nature Publishing Group US,Nature Publishing Group
Subject
This website uses cookies to ensure you get the best experience on our website.